227 related articles for article (PubMed ID: 30389140)
1. Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.
Yoshimura T; Saitoh K; Sun L; Wang Y; Taniyama S; Yamaguchi K; Uchida T; Ohkubo T; Higashitani A; Nikawa T; Tachibana K; Hirasaka K
Biochem Biophys Res Commun; 2018 Dec; 506(4):773-779. PubMed ID: 30389140
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
3. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
[TBL] [Abstract][Full Text] [Related]
5. Dietary Supplementation with Isoflavones Prevents Muscle Wasting in Tumor-Bearing Mice.
Hirasaka K; Saito S; Yamaguchi S; Miyazaki R; Wang Y; Haruna M; Taniyama S; Higashitani A; Terao J; Nikawa T; Tachibana K
J Nutr Sci Vitaminol (Tokyo); 2016; 62(3):178-84. PubMed ID: 27465724
[TBL] [Abstract][Full Text] [Related]
6. Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models.
Sun R; Zhang S; Lu X; Hu W; Lou N; Zhao Y; Zhou J; Zhang X; Yang H
Oncol Rep; 2016 Dec; 36(6):3291-3302. PubMed ID: 27748895
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
8. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
[TBL] [Abstract][Full Text] [Related]
9. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia.
Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A
Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662
[TBL] [Abstract][Full Text] [Related]
10. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
[TBL] [Abstract][Full Text] [Related]
11. Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia.
Cardaci TD; VanderVeen BN; Bullard BM; McDonald SJ; Unger CA; Enos RT; Fan D; Velázquez KT; Frizzell N; Spangenburg EE; Murphy EA
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):124-137. PubMed ID: 38062911
[TBL] [Abstract][Full Text] [Related]
12. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.
Zhang G; Liu Z; Ding H; Miao H; Garcia JM; Li YP
Sci Rep; 2017 May; 7(1):2273. PubMed ID: 28536426
[TBL] [Abstract][Full Text] [Related]
14. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
[TBL] [Abstract][Full Text] [Related]
15. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue browning in cancer-associated cachexia can be attenuated by inhibition of exosome generation.
Hu W; Ru Z; Xiao W; Xiong Z; Wang C; Yuan C; Zhang X; Yang H
Biochem Biophys Res Commun; 2018 Nov; 506(1):122-129. PubMed ID: 30340833
[TBL] [Abstract][Full Text] [Related]
17. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
[TBL] [Abstract][Full Text] [Related]
18. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice.
Blackwell TA; Cervenka I; Khatri B; Brown JL; Rosa-Caldwell ME; Lee DE; Perry RA; Brown LA; Haynie WS; Wiggs MP; Bottje WG; Washington TA; Kong BC; Ruas JL; Greene NP
Physiol Genomics; 2018 Dec; 50(12):1071-1082. PubMed ID: 30289747
[TBL] [Abstract][Full Text] [Related]
20. REDD1 deletion attenuates cancer cachexia in mice.
Hain BA; Xu H; VanCleave AM; Gordon BS; Kimball SR; Waning DL
J Appl Physiol (1985); 2021 Dec; 131(6):1718-1730. PubMed ID: 34672766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
